English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Simple Summary  Endemic Burkitt lymphoma (eBL) is a common pediatric cancer in sub-Saharan Africa. The incidence of this aggressive B-cell cancer is linked to  Plasmodium falciparum (Pf)  malaria and Epstein–Barr virus (EBV) co-infections during childhood. Most eBL tumors contain EBV and are characterized by the Epstein–Barr Nuclear Antigen 1 (EBNA1) latency I pattern of viral gene expression. The aim of our study was to compare the phenotypes and functions of CD4 +  and CD8 +  T cell responses to EBNA1 in children diagnosed with eBL and in healthy EBV-seropositive children to highlight differences that contribute to the balance between anti-viral immunity and eBL pathogenesis.    Abstract  Children diagnosed with endemic Burkitt lymphoma (eBL) are deficient in interferon-γ (IFN-γ) responses to Epstein–Barr Nuclear Antigen1 (EBNA1), the viral protein that defines the latency I pattern in this B cell tumor. However, the contributions of immune-regulatory cytokines and phenotypes of the EBNA1-specific T cells have not been characterized for eBL. Using a bespoke flow cytometry assay we measured intracellular IFN-γ, IL-10, IL-17A expression and phenotyped CD4 +  and CD8 +  T cell effector memory subsets specific to EBNA1 for eBL patients compared to two groups of healthy children with divergent malaria exposures. In response to EBNA1 and a malaria antigen ( Pf SEA-1A), the three study groups exhibited strikingly different cytokine expression and T cell memory profiles. EBNA1-specific IFN-γ-producing CD4 +  T cell response rates were lowest in eBL (40%) compared to children with high malaria (84%) and low malaria (66%) exposures ( p  < 0.0001 and  p  = 0.0004, respectively). However, eBL patients did not differ in CD8 +  T cell response rates or the magnitude of IFN-γ expression. In contrast, eBL children were more likely to have EBNA1-specific CD4 +  T cells expressing IL-10, and less likely to have polyfunctional IFN-γ + IL-10 +  CD4 +  T cells ( p  = 0.02). They were also more likely to have IFN-γ + IL-17A + , IFN-γ +  and IL-17A +  CD8 +  T cell subsets compared to healthy children. Cytokine-producing T cell subsets were predominantly CD45RA + CCR7 +  T NAIVE-LIKE  cells, yet PD-1, a marker of persistent activation/exhaustion, was more highly expressed by the central memory (T CM ) and effector memory (T EM ) T cell subsets. In summary, our study suggests that IL-10 mediated immune regulation and depletion of IFN-γ +  EBNA1-specific CD4 +  T cells are complementary mechanisms that contribute to impaired T cell cytotoxicity in eBL pathogenesis.

cancers

Interplay between IL-10, IFN-γ, IL-17A and PD-1 Expressing EBNA1-Specific CD4+ and CD8+ T Cell Responses in the Etiologic Pathway to Endemic Burkitt Lymphoma